Other
Serum Raman spectroscopy intelligent diagnostic system
Total Trials
5
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Other(1)
Detailed Status
Not yet recruiting4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
N/A
Trials by Status
unknown120%
not_yet_recruiting480%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruiting
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
NCT06775002
not_yet_recruiting
SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
NCT06772363
not_yet_recruiting
SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules
NCT06775587
not_yet_recruiting
SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer
NCT06775015
unknown
Multicenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate Cancer
NCT05854940
Clinical Trials (5)
Showing 5 of 5 trials
NCT06775002
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
NCT06772363
SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
NCT06775587
SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules
NCT06775015
SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer
NCT05854940
Multicenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 5